Stroke Scale (NIHSS) score. 4, 5 However, for acute ischemic stroke patients receiving EVT, NIHSS scores may change dramatically and the magnitude of change is quite variable even with substantial reperfusion. 6 Such variation implies that final revascularization status or infarct volume alone cannot accurately reflect individual responses to reperfusion. It was recently reported that the early trajectory of NIHSS scores within 2 days predicts functional outcomes with greater accuracy.
ndovascular recanalization therapy (EVT) is a standard therapy for acute ischemic stroke with major occlusions in the anterior circulation. 1 Individual responses to EVT vary greatly, and ≈40% of patients become dependent or die despite achieving substantial reperfusion. 2 To achieve better outcomes after recanalization treatments, stroke researchers are trying to test various neuroprotective or anti-inflammatory agents during the acute stroke period.
estimating individual prognosis and evaluating the efficacy of medical interventions after reperfusion therapy.
In this context, we investigated the prognostic utility of post-EVT NIHSS score for 3-month functional outcome. We compared discrimination powers of different statistical models composed of clinical variables including initial NIHSS score, revascularization status, and post-EVT NIHSS score by analyzing prospectively acquired data of consecutive patients who underwent EVT.
Methods

Study Patients
This study was a retrospective analysis of prospectively collected data from a clinical registry. The data that support the findings of this study are available from the corresponding author on reasonable request. Among 8135 consecutive stroke patients who were admitted to Seoul National University Bundang Hospital between April 2008 and December 2015, we identified patients who met the following inclusion criteria: (1) patients who had ischemic strokes with documented lesions (n=6878), (2) patients who had received EVT (n=650), and (3) patients whose prestroke modified Rankin Scale (mRS) scores were 0 to 2 (n=590). We excluded 24 patients because of the following reasons: (1) post-EVT NIHSS scores were missing because EVT was performed at another hospital (n=16), (2) post-EVT NIHSS score was unmeasurable because of deep sedation or anesthesia (n=6), and (3) 3-month mRS score not measured because of loss to follow-up (n=2). Finally, 566 patients were included in this analysis ( Figure I in the online-only Data Supplement).
Acute stroke management was performed according to the institutional protocols primarily based on the current guidelines and the discretion of the stroke physicians with direct responsibility. [8] [9] [10] Activation of clinical pathway for hyperacute stroke and EVT was done within 12 hours from the time symptoms first observed in this study. The implementation of EVT was determined primarily by visual inspection of diffusion images and perfusion maps with clinical considerations. Informed consent was obtained from the study participants or their relatives to assess long-term outcomes. The analyses were approved by the Institutional Review Board at Seoul National University Bundang Hospital (approval No. B-1710-429-106). The clinical data and patient outcomes were primarily collected for our hospital's quality improvement program.
Definitions Regarding Baseline Information
We collected baseline demographic and clinical information for all study participants, including their age, sex, prestroke mRS score, initial systolic and diastolic blood pressure, prestroke antithrombotic use, prestroke statin use, and stroke risk factors. Stroke risk factors included hypertension (defined as previous use of antihypertensive medication, systolic blood pressure >140 mm Hg; diastolic blood pressure >90 mm Hg at discharge), diabetes mellitus (defined as previous use of glucose-lowering medication or hemoglobin A1C ≥6.5%), hyperlipidemia (defined as previous use of lipid-lowering medication, fasting low-density lipoprotein cholesterol >160 mg/ dL, or fasting total cholesterol >240 mg/dL), smoking (current or exsmoker), and atrial fibrillation. Stroke subtypes were determined via the modified TOAST (Trial of ORG 10172 in Acute Stroke Treatment) classification system. 11 We obtained laboratory information including leukocyte counts, hemoglobin, initial glucose, hemoglobin A1c, total cholesterol, triglycerides, and high-and low-density lipoprotein cholesterol levels. The treatment information included the NIHSS score on admission, preceding intravenous tissue-type plasminogen activator use, time from onset to EVT, stroke location (anterior versus posterior circulation), and stent-retriever use during EVT. The time of onset was defined as the time at which the patient was last observed to be normal, and the time of EVT was defined according to the time at which the groin was punctured.
Assessment of Post-EVT NIHSS Score and Revascularization Status
We prospectively collected post-EVT NIHSS scores in our registry. Post-EVT NIHSS was measured by an on-duty physician immediately after completion of EVT in the angiography suite or on stroke unit admission. All evaluators were NIHSS certified. Revascularization status was assessed on the final angiogram and was classified according to the modified Thrombolysis in Cerebral Infarction (mTICI) grade 12 by a board-certified interventional neuroradiologist with years of clinical experience (C. Jung).
Study Outcome
mRS scores at 3 months after index stroke were prospectively collected via telephone interview or a clinic visit by an experienced and trained research nurse (M.H. Yang). A favorable clinical outcome was defined as an mRS score of 0 to 2.
Statistical Analyses
Baseline characteristics and stroke information between poor (mRS score of 3-6) and favorable (mRS score of 0-2) outcome groups were compared by χ 2 test for categorical variables and independent sample t test for interval variables. The prognostic value of post-EVT NIHSS, mTICI grade, and other known predictors in predicting favorable 3-month outcome were assessed using multivariable logistic regression analysis. Model 1 included age, sex, premorbid mRS, initial NIHSS score, time from onset to EVT, r-tPA use, stroke location, stent-retriever use, and initial glucose. mTICI (model 2), post-EVT NIHSS (model 3), or mTICI plus post-EVT NIHSS (model 4) were added to all predictors of model 1 ( Figure II in the onlineonly Data Supplement). Multicollinearity among the covariates was tested by examining whether the variance inflation factor is ≥4. For each model, we presented odds ratios with 95% confidence intervals to describe the effect size of each predictor. C statistic was used as a measure of predictive accuracy and all models were compared by using the DeLong method. 13 We also calculated and compared the integrated discrimination index and the continuous net reclassification index across all models.
14,15 Bonferroni correction was made for all comparisons tested. Prespecified subgroup analysis was done for patients whose mTICI grade after EVT was 2b or 3. We further performed sensitivity analysis for patients with time from onset to EVT <6 hours, initial NIHSS score ≥6, or stent-retriever use. The significance levels were set at a P value of <0.05 for 2-tailed tests. The statistical analyses were performed using R for statistical computing version 3.3.2.
Results
In a total of 566 eligible patients, 60.1% were men (n=340) and the mean age was 69.3±11.7 years. Intravenous tPA before EVT was used in 49.8% (n=282). The median delay of onset to EVT start was 4.8 hours (interquartile range, 2.7-10.6 hours), EVT start to reperfusion was 42 minutes (interquartile range, 21-81 minutes), and EVT finish to admission was 35 minutes (interquartile range, 24-59.75 minutes; Table I in the online-only Data Supplement). Stent retriever was used in 63.4% (n=359) as a primary recanalization device. mTICI score 2b and 3 was achieved in 42.4% (n=240) and 38.5% (n=218) of the patients, respectively. Favorable functional outcome (mRS score of 0-2 at 3 months) was achieved in 47.9% (n=271) of patients. Other patient characteristics include risk factors, stroke mechanisms, and laboratory information are described in Table 1 .
The median of initial and post-EVT NIHSS score were 14 (9-19) and 11 (5-17) points, respectively. Compared with the initial score, post-EVT NIHSS score was improved in 58.8%,
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April 2018 same in 20.7%, and deteriorated in 20.5% of the patients. The trajectory from baseline NIHSS score to 3-month mRS is demonstrated in Figure 1 ; Table II and Figure III in the onlineonly Data Supplement. We constructed 4 different multivariable logistic regression models ( Table 2 ). Model 1 included baseline predictors such as age, sex, premorbid mRS, time from onset to EVT, intravenous thrombolysis, posterior circulation, stent-retriever use, glucose, and baseline NIHSS score. Model 2 was constructed with model 1 adding mTICI score; model 3 with model 1 adding post-EVT NIHSS score; and model 4 with model 1 adding both mTICI and post-EVT NIHSS score. Based on the results of differences among the C statistics, both model 3 (C statistic, 0.896; 95% confidence interval, 0.870-0.922) and model 4 (C statistic, 0.906; 95% confidence interval, 0.881-0.930) were significantly more discriminative of favorable functional outcome than model 1 (C statistic, 0.802; 95% confidence interval, 0.766-0.837) or model 2 (C statistic, 0.834; 95% confidence interval, 0.801-0.867; Table 3; Figure 2 ). Additionally, to estimate the discrimination performance by mTICI and post-EVT NIHSS more sensitively, we compared the probabilities of events and nonevents of models using the relative integrated discrimination index and category-free net reclassification index. Model 4 showed significant improvement of both integrated discrimination index and categoryfree net reclassification index as compared with model 1, 2, or 3, but the magnitude of improvement from model 3 to model 4 (integrated discrimination index, 0.021; net reclassification index, 0.322) was small.
In a subgroup analysis of patients with successful recanalization (mTICI 2b or 3; 80.9% [n=458]), both model 3 and model 4, including post-EVT NIHSS score, showed better performance than model 1 or model 2. However, the addition of mTICI grade in models (model 4 versus model 3 or model 2 versus model 1) did not confer further discriminating values (Tables III and IV in the online-only Data Supplement). As sensitivity analyses, the performance of each model was tested in patients with time from onset to EVT within 6 hours, initial NIHSS score ≥6, and stent-retriever use, which showed similar magnitude of improved performance by adding post-EVT NIHSS score (Table V in the online-only Data Supplement). In posterior circulation stroke, model discrimination by post-EVT NIHSS score was less robust as compared with anterior circulation stroke (Table VI in the online-only Data Supplement). The discriminative value of post-EVT NIHSS score well-maintained in the models including all significant covariates (Table VII in the onlineonly Data Supplement).
Discussion
We performed a retrospective study on the prognostic utility of post-EVT NIHSS score for predicting the 3-month functional outcome in ischemic stroke patients who underwent EVT, by comparing discrimination powers of different statistical models comprising clinical variables including initial NIHSS score, revascularization status, and post-EVT NIHSS score. This study demonstrates that incorporating revascularization status or neurological deficits after reperfusion treatments will confer better discrimination power than a traditional model of only baseline characteristics for functional recovery. Post-EVT NIHSS score can be more useful as an important baseline prognostic variable, when evaluating adjuvant neuroprotective therapies administered immediately after EVT. Moreover, post-EVT NIHSS seems to be more accurate than mTICI grade to estimate 3-month prognosis, because post-EVT NIHSS may partly distinguish clinically effective reperfusion from futile or no reperfusion. Timely revascularization is the key to success in hyperacute ischemic stroke treatments. 16 Despite substantial reperfusion, however, a substantial number of futile recanalization cases remain with unsatisfactory recoveries. 2 When any neuroprotective agents or experiments are considered, the baseline characteristics of candidates should intuitively be the posttreatment ones. Our results, which present the implication of posttreatment variables for the prediction of functional recovery from hyperacute ischemic stroke patients, would be utilized as a guidance in designing observational or randomized studies.
Not all effects of EVT are reflected in immediate post-EVT NIHSS. The patients can gradually improve after EVT or develop delayed neurological or medical complications, which affects long-term functional outcomes. However, a recent study demonstrated that an early trajectory of NIHSS score within first 48 hours after EVT predicts functional outcome with high accuracy, 7 which suggests early response after EVT can explain much of the long-term outcomes. The usefulness of post-EVT NIHSS score as baseline prognostic variable lies in evaluating adjuvant therapies after EVT, in which NIHSS score at 24 hours or after cannot be considered in decision-making or affected by the adjuvant therapy. In this regard, post-EVT NIHSS score may not be useful in clinical trials evaluating neuroprotective agents as temporizing therapy, 3, 17 in which the agents are administered before or during EVT. Even in these cases, however, consideration of post-EVT NIHSS score is necessary to discriminate between the effects of reperfusion and neuroprotective agents, as ultraearly improvement after EVT is mainly because of reperfusion rather than the adjuvant therapies.
There are some caveats in interpreting this study. This study has limited generalizability because of its retrospective design involving patients' data at a single center, requiring a prospective validation study for the suggested prognostication methods. The exact measurement time of post-EVT NIHSS cannot be provided from our data set but is quite likely to be in the same time as EVT finish to admission. The post-EVT NIHSS score cannot be used when it is difficult to measure reliably because of general anesthesia or deep sedation during the procedure. Since this study was based on 8 years of data from a single-center stroke registry, there may be differences in the characteristics of patients compared with those on recommended in the current EVT guideline. 1 However, in sensitivity analyses about baseline NIHSS score, time from onset to EVT, and stent-retriever use, the discrimination power of post-EVT NIHSS score was constant. The Alberta Stroke Program Early CT Score was not incorporated in the models, as the score had not been routinely used in our clinical practice.
In conclusion, incorporation of post-EVT NIHSS score provides better discrimination power to the models for functional recovery after EVT. We suggest that when evaluating the effect of adjuvant therapy or biomarkers on prognosis after EVT, post-EVT NIHSS score needs to be considered as another baseline neurological status. Randomized controlled trials for adjuvant therapies after EVT also need to consider post-EVT NIHSS score as an important baseline marker to minimize potential bias, because mTICI alone may not discriminate clinically successful reperfusion from futile reperfusion. 
